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Glycosylation is a highly complex process to produce a diverse repertoire 
of cellular glycans that are attached to proteins and lipids. Glycans are 
involved in fundamental biological processes, including protein folding 
and clearance, cell proliferation and apoptosis, development, immune 
responses, and pathogenesis. One of the major types of glycans, N-linked 
glycans, is formed by sequential attachments of monosaccharides to 
proteins by a limited number of enzymes. Many of these enzymes can 
accept multiple N-linked glycans as substrates, thereby generating a large 
number of glycan intermediates and their intermingled pathways. 
Motivated by the quantitative methods developed in complex network 
research, we investigated the large-scale organization of such N-linked 
glycosylation pathways in mammalian cells. The N-linked glycosylation 
pathways are extremely modular, and are composed of cohesive 
topological modules that directly branch from a common upstream 
pathway of glycan synthesis. This unique structural property allows the 
glycan production between modules to be controlled by the upstream 
region. Although the enzymes act on multiple glycan substrates, 
indicating cross-talk between modules, the impact of the cross-talk on the 
module-specific enhancement of glycan synthesis may be confined within 
a moderate range by transcription-level control. The findings of the 
present study provide experimentally-testable predictions for 
glycosylation processes, and may be applicable to therapeutic 
glycoprotein engineering. 
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Introduction 
 
 Carbohydrates are a basic cell constituent, and are one of the most abundant and 
diverse biopolymers in nature [1]. Complex carbohydrates have recently become widely 
recognized as more than just a metabolic energy source [2–6]. For example, the cell 
surface contains a layer of complex carbohydrates involved in signalling roles that are 
indispensable to multicellular organisms [2,7]. Glycosylation, the attachment of glycans 
(oligosaccharides) to proteins or lipids, is a ubiquitous post-translational modification 
that generates an extensive functional capability from a limited set of genes [8–10]. In 
contrast to gene and protein sequences, the glycosylated glycan sequences are not 
arranged in a simple linear chain [5]. Several monosaccharides can be placed 
simultaneously on a particular monosaccharide, forming branched structures that 
provide enormous glycan structural diversity. 
 Vertebrates, and especially mammals, have evolved a unique glycan repertoire which 
is structurally distinct from that of nonvertebrate organisms [2,8–10]. Mammalian cells 
are used as host cell systems for the production of many recombinant glycoproteins; 
these systems can synthesize properly folded proteins with glycans resembling those in 
human bodies [11,12]. N-Linked and O-linked glycans are the major contributors to the 
structure and function of mammalian secretory glycoproteins. N-Linked glycans are 
attached to asparagine residues of proteins, located within the Asn-X-Ser/Thr motif of 
amino acids, where X can be any amino acid except proline. 
 N-Linked glycosylation occurs co-translationally in the endoplasmic reticulum (ER) 
compartment. The addition of an oligosaccharide to the peptide at an early stage of 
glycoprotein synthesis allows the glycan to participate in the folding and quality control 
of a newly synthesized protein [13]. Upon successful folding of the protein and the 
trimming of some residues in the glycan, the glycoprotein migrates into the Golgi 
apparatus. Processing in the Golgi involves the removal of mannose groups and the 
addition of various monosaccharides to the growing glycan. The removal of the 
mannose groups is driven by mannosidases, and the addition of different 
monosaccharides is facilitated by specific glycosyltransferases. Thus, N-linked 
glycosylation pathways comprise consecutive enzymatic steps that rely on the glycan 
structures produced by the previous enzyme to produce the substrate for the next 
enzyme. The pathways formed in this process diverge when a glycan is a substrate for 
multiple enzymes, or converge when multiple glycan substrates all lead to the same 
product. Many glycan intermediates at different loci along the pathways, not necessarily 
glycans at the termini, can be secreted out of the Golgi to the targeted sites where they 
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perform biological functions, such as mediating cell growth and development, cell-cell 
communication, immune recognition/response, and molecular homeostasis [2,7–10,14]. 
 Recent advances in understanding the generic properties of complex networks, 
including various biological, technological, and social networks [15,16], allow for a 
quantitative examination of the organization of N-linked glycosylation pathways. This 
development in network research has been driven largely by the availability of massive 
digital records and statistical methods that permit network data to be collected and 
analyzed on a scale far larger than previously possible. The emerging results in complex 
network research have led to the realization that, notwithstanding the importance of 
individual molecules, cellular phenotype is a contextual attribute of seamless and 
quantifiable network patterns among numerous constituents [17]. Despite the key role 
of glycosylation pathways in sustaining many biological functions, their large-scale 
properties have not yet been characterized from a complex network perspective. 
Understanding the global organization of complex networks will provide valuable and 
perhaps unique topological information, and may also lead to a better understanding of 
the dynamical and evolutionary processes of the networks, as demonstrated in several 
other biochemical systems, such as metabolic networks and protein-protein interaction 
networks [18–22]. Here, we explore whether the organization of glycosylation pathways 
can be elucidated from a complex network perspective, by investigating the structural 
and regulatory properties of N-linked glycosylation pathways in mammalian cells. Our 
findings don’t only have the implications in the organizing principle of cellular 
glycosylation processes, but also in the glycoprotein engineering to be applicable for 
therapeutic purposes. 
 
Results 
 
Topological Properties and Modularity 
 We constructed N-linked glycan biosynthetic pathways by incorporating ten typical N-
linked glycosylation enzymes in mammalian cells and their substrate specificities 
(Table 1; see also Materials and Methods). These enzymes can accept multiple N-linked 
glycans as substrates, and are thus capable of generating a large number of glycan 
intermediates. Construction was initiated from 9-mannose glycan, the common 
precursor of N-linked glycans in the Golgi, and followed by biosynthetic steps to 
produce mainly complex-type glycans (Figure 1), giving rise to a glycosylation network 
composed of 638 glycans and 1499 enzymatic reactions (Figure 2A). 
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Figure 1. Glycan structures considered in network construction. 9-Mannose glycan enters 
the N-linked glycan biosynthetic pathways as the starting substrate (left), and can be processed 
into a fully sialylated complex-type glycan (right). Symbols indicate the sugar residues 
according to the CFG nomenclature [45]. GlcNAc: N-acetylglucosamine; Man: mannose; Fuc: 
fucose; Gal: galactose; NeuAc: sialic acid. 
 
 
 Central and peripheral regions.  The essentiality of a particular glycan in the 
glycosylation network was assessed by counting the number of all downstream 
substrates that could not be produced in the absence of the given glycan. Following the 
terms in complex network research, this might be analogous to evaluating the avalanche 
size of a network after perturbing a single vertex [23–25]. Figure 2B shows that for 
most glycans (95.8%) the absence of an individual glycan did not affect any glycan 
production or only hindered the production of fewer than three glycans. On the other 
hand, the impact of the removal of the few remaining glycans (4.2%) spread over a wide 
range, even up to the damage at the whole system level. These minor, but highly-
impacting glycans tended to be located adjacent to each other, thereby occupying a 
single clustered region in the pathways. Therefore, the clustered region could be easily 
distinguished from the other parts of the network, and was termed the central region 
(Materials and Methods). The central region consisted of one connected component of 
glycans, including the initial input substrate, and the non-central or peripheral region 
was bound to and derived from this central region. 
 Modular structure.  The spectral method developed for graph partitioning 
(Materials and Methods) revealed that the peripheral region comprised 21 tightly-knit 
subgraphs. These 21 subgraphs or modules are densely connected groups of glycans, 
with only sparser connections between groups. Therefore, the modules tend to be 
biosynthetically isolated from each other. This biosynthetically-modular property of the 
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pathways originates from the substrate specificity of the enzymes considered here, as 
described below, rather than from simple differences in individual glycan structures that 
the conventional scheme for glycan classification [2] has been based on. Interestingly, 
each module in the peripheral region was generated from only a few roots, all of which 
belonged to the central region (Figures 2A and S1). In other words, N-linked 
glycosylation pathways organized their modular structure in a highly centralized 
manner; the central region with a small number of glycans proliferated directly into all 
21 modules in the peripheral region, thereby forming a star-like structure. Indeed, direct 
connections between different peripheral modules were relatively sparse compared with 
those between the central and peripheral regions (Figures S1 and S2). Remarkably, the 
glycosylation network had unusually high modularity (Q = 0.83) compared with other 
biological and non-biological networks [26], suggesting that glycosylation-specific 
evolutionary pressure was required for the development of such a unique network 
structure. 
 The number of glycans across modules was unevenly distributed, with the largest 
module containing 40-fold more glycans than the smallest module. The discrete jumps 
between module sizes in Figure 2C indicate that the size of each module was due to the 
complexity of the terminal glycan structures. Specifically, the more processed the 
terminal glycans were with N-acetylglucosamines (GlcNAc) following α1,3- and α1,6-
linked mannoses, the greater the number of glycan species that developed in the module. 
This glycan enrichment pattern across modules comes from the inherent capability of 
carbohydrates to add branches [5] to the mannose residues, which exponentially 
diversifies the glycan structures. 
 Enzymatic contribution.  To better understand the modular properties of the 
glycosylation network, we further investigated the enzymatic reactions involved in 
module formation. Reactions from the central to the peripheral region – entry reactions 
into the peripheral modules – were dominated by galactosylation (93.5% of the 
reactions; see also Figures 2A and S1). Galactosylation and concurrent sialylation also 
dominated the reactions (99.0%) occurring within the peripheral modules (Figure 2A), 
while the reactions between these modules mostly comprised GlcNAc addition (Figure 
S2). On the other hand, in the central region, all enzymes except galactosyltransferase 
(GalT) and sialyltransferase (SiaT) were involved in the reactions (Figure 2A). 
 These findings suggest the enzymatic mechanisms that are responsible for generating 
the unique modular structure of the glycosylation network, as highlighted by the role of 
GalT: GalT are generous in their substrate specificity, accepting any substrate with free 
GlcNAc on the mannose branches, and multiple products arise from the same substrate 
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depending on the specific galactosylated residues. Once glycans are galactosylated, 
however, they inhibit the approach of many other enzymes (Table 1). Such tolerance in 
substrate specificity and product formation facilitates the development of redundant 
pathways within each module, whereas the inhibition of other enzyme activities keeps 
different modules separated. The effect of such inhibition for module differentiation was 
also observed from another enzyme, β-1,4-mannosyl-glycoprotein 4-β-N-
acetylglucosaminyltransferase (GnTIII). GnTIII adds bisecting GlcNAc to its substrate, 
and the presence of bisecting GlcNAc inhibits the activity of many enzymes (Table 1). 
Therefore, the bisecting GlcNAc is thought to insulate relevant modules, as shown in 
Figure S2 where the junctions of different modules only contain glycans without 
bisecting GlcNAc. Accordingly, if we exclude the glycan syntheses catalyzed by GnTIII, 
then the network becomes slightly less modular (Q = 0.72) as the well-insulated 
modules selectively disappear. We believe that this organizing principle of modular 
structures manifested by GalT as well as by GnTIII offers a useful guideline for the 
engineering of novel glycosyltransferases, as discussed below. 
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Figure 2. Modular organization of N-linked glycosylation pathways. (A) The global 
topology of the constructed N-linked glycosylation pathways. Circles stand for glycan species 
and arrows for enzymatic reactions from substrates to products. The size of each circle 
represents the impact on the pathways in the absence of the corresponding glycan. Circles and 
arrows are colored according to the positions in the pathways and the catalyzing enzymes, 
respectively. We depict the structures of some early and terminal glycans using the symbols in 
Figure 1. Glycan synthetic modules are labelled in the ascending order of the number of the 
participating glycans. (B) In the absence of each glycan, the number of extinguished 
downstream glycans is shown on the horizontal axis, and the vertical axis shows the number of 
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such absent glycans leading to the same effect. The criterion of the central region is indicated by 
the arrow at the horizontal axis (Materials and Methods). (C) The number of glycans 
participating in each module. Module indices on the horizontal axis follow those appearing in 
(A). At the top in the horizontal direction, we show the number of GlcNAc on mannose 
branches that each terminal glycan has in a corresponding module. 
 
 
Regulatory Properties and Cross-Talk 
 The highly modularized, yet centralized organization of N-linked glycosylation 
pathways raises the question of how cells enhance or suppress the glycan production 
across modules against distinct physiological conditions. Within the same module, 
glycans are easily convertible to other glycans along densely connected pathways, 
whereas the conversion of glycans between different modules, which are only sparsely 
connected, is more difficult. Furthermore, glycans in the peripheral modules are 
surrounded by homogeneous enzymatic reactions (catalyzed mostly by GalT and SiaT 
in the Golgi), and are thus not as likely to be regulated but routed randomly along the 
pathways. Glycans along such unregulated routes are thought to be trapped for a long 
time in a particular module because there are few paths through which they can enter 
the other modules [27]; therefore, glycans delivered from the central region might 
continue to be processed inside the arrival modules until they are eventually secreted 
out of the Golgi. In this regard, the paths glycans take through the central region ahead 
of the peripheral modules likely play a critical role in the end-product formation. 
 Specific reactions in the central region may be manipulated by the transcriptional 
regulation of enzyme expression. Previous experiments demonstrated a correlation 
between glycan production and transcript expression of the corresponding enzymes. For 
example, the abundance of bisected glycoforms and of GnTIII transcript as well as that 
of fucosylated glycoforms and of glycoprotein 6-α-L fucosyltransferase (FucT) 
transcript is positively correlated across different mouse tissues [28–30]. The 
heterogeneous enzyme pools in the central region favor such specific transcriptional 
control. Glycosylation enzymes, however, are usually involved in multiple reactions; a 
change in the abundance of a single enzyme is likely to affect more than one reaction in 
the central region, and a number of modules derived from the affected reactions will 
also be affected. Therefore, it is important to assess specifically how to control these 
modules that share the common upstream enzymes to result in the cross-talk between 
the modules. 
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 We considered combinations of up- and down-regulation of glycosylation enzymes 
that would unambiguously predict changes in glycan syntheses, and for each case, we 
determined which modules would enhance or suppress glycan production relative to 
their basal levels (Materials and Methods). Figure 3A shows one such result in which 
the down-regulation of GnTIII, α-1,3-mannosyl-glycoprotein 4-β-N-
acetylglucosaminyltransferase (GnTIV), and FucT led to the enhancement of the 1st and 
16th modules, but also to the suppression of the other modules. Minimizing cross-talk 
or unwanted enhancement of modules other than those specified requires an 
orchestrated regulation across enzymes. Under the regulation to minimize such cross-
talk, Figures 3B and 3C show that each enhancement of three-quarters of the modules 
was accompanied by the unwanted enhancement of less than one-third of the modules, 
and the enhancement of the remaining modules could be at most accompanied by the 
unwanted enhancement of less than one-half of the modules. Consequently, although 
the cross-talk between modules is not negligible, the effect on glycan synthesis is 
confined within a moderate range, and probably further reduced by post-transcriptional 
regulation or by other combinations of enzyme regulation which were excluded here for 
clarity. 
 The explicit prediction of modules to be enhanced under given transcriptional 
regulation (Table S1) can be tested experimentally by measuring the change in the 
glycan production after genetic manipulation and identifying the relevant modules. For 
example, the production of glycans belonging to the 1st and 16th modules (Figure S1) is 
supposed to be increased after gene knockdown of GnTIII, GnTIV, and FucT, as 
indicated in Figure 3A. It should be noted that the glycan production here was 
quantified by the amount of flux into the glycan synthesis, rather than by the glycan 
abundance itself. Therefore, measuring only the abundance of secreted glycans and not 
the abundance of all the glycan intermediates will be more relevant in this case. 
Experimental validation of this prediction will allow us to design genetic regulation to 
enhance glycan synthesis in targeted modules. For example, if some modules contain 
desirable glycoproducts like biopharmaceuticals, then genetic regulation can be applied 
to enhance the glycan synthesis in these modules, and accordingly, to increase the 
production rate of the biopharmaceutical glycans. Such genetic regulation toward 
specific module enhancement might also be applied to reduce the heterogeneity of 
glycoforms and to improve the consistency of glycoprotein production [11,12]. 
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Figure 3. Regulation of glycan synthesis. (A) Enhancement of glycan production in specific 
modules is illustrated with a part of the pathways in Figure 2(A). The down-regulation of 
GnTIII, GnTIV, and FucT weakens the reactions crossed by red lines, thus strengthening the 
other reactions toward the 1st and 16th modules, as highlighted. (B) The modules to be 
enhanced or suppressed under combinations of enzyme up- and down-regulation. Here we show 
only the cases where six or fewer modules become enhanced, and exclude the indices of the 
modules that are never enhanced in these cases. Each row displays a unique pattern of module 
enhancement resulting from certain regulatory combinations, and is labelled as shown in Table 
S1. Enhanced modules are colored blue or green, and suppressed ones are indicated in white. 
The row including greens is for the case demonstrated in (A). (C) From the lists of modules to 
be enhanced together with a given module on the horizontal axis, we enumerated the minimum 
number of such co-enhanced modules as shown in the vertical axis. Blue is for less than or 
equal to 6 in the minimum number, obtained from the module enhancement pattern shown in 
(B). 
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Discussion 
 
 The complexity and biological significance of protein glycosylation have long been 
underestimated, and now, in the post-genomic era, are at the forefront of scientific 
research. It is increasingly appreciated that biological systems exploit glycosylation in 
synthesizing cell-surface glycans to organize plasma membrane receptors and control 
the recruitment of intracellular signal transduction mediators. Hence, further knowledge 
of glycobiology will contribute to deciphering a myriad of biological phenomena. 
Clearly, a systems-level understanding of glycosylation processes will advance such 
scientific achievement. The N-linked glycosylation pathways comprise very distinct 
topological modules, all directly stemming from the common upstream pathway termed 
the central region. This central region might act as a ‘control tower’ of glycan 
production by redistributing glycan synthesis fluxes over the modules to adapt to 
different physiological conditions. Cross-activation or cross-talk between the modules, 
however, will restrict the fine-tuning level of the flux distribution. The topological 
properties of such N-linked glycosylation pathways were elucidated from a complex 
network viewpoint that further helps set the hypotheses on implicated functional and 
evolutionary properties. 
 The underlying mechanism of module development is clarified by the role of GalT, 
which accepts a wide range of substrates and makes multiple products to inhibit many 
other enzyme activities. The tolerance in glycan synthesis and the inhibition of other 
enzyme activities contribute to module formation and differentiation, respectively, 
while the latter is also observed similarly in the case of GnTIII. The significant 
influence of GalT in pathway formation provides a pattern for the design of novel 
glycosyltransferases to implant another module that does not severely disturb the pre-
existing pathways. Such construction or evolution of a new module would not 
significantly hamper the functioning of the old modules, and are thus favorable both for 
engineering purposes and for evolution, which could be facilitated [31] by this module-
level modification. Specifically, the sugar residues attached by these novel enzymes 
should not inhibit galactosylation and sialylation. On the other hand, the enzymes 
should not accept already-galactosylated substrates. If these two rules are satisfied, then 
the enzymes will synthesize glycans at the central region introducing a new module in 
the peripheral region. Interestingly, GnTIII satisfies both rules, and this might be one 
reason why GnTIII works properly in recombinant Chinese Hamster Ovary (CHO) cells 
although it is not present in wild-type CHO [32–35]. In addition, CHO cells transfected 
with GnTIII are utilized in industry for the production of antibodies that significantly 
 12 
improve antibody-dependent cellular cytotoxicity and treat neuroblastoma and non-
Hodgkin’s lymphoma [34,35]. 
 More immediate applications for glycoprotein engineering might arise from the 
relationship between transcriptional regulation and glycan production, as described 
above. Orchestrated regulation of enzyme expression in the central region will allow 
glycan production to be enhanced in specific modules, while avoiding moderately the 
increased production of other unwanted modules. Possible deviations between the 
prediction and the empirical data may arise due to incompleteness in modelling or 
regulation at a post-transcriptional level of which the potential effects on glycosylation 
remain largely unknown. Further integration of poly-N-acetyllactosamine structures and 
many degradation mechanisms will dress up the pathways considered here, and the 
original pathways can be viewed as an organizational kernel [36] of which the main 
properties we expect to be still reflected in more complicated pathways. Various 
techniques used to study metabolic flux analysis are also expected to allow for in-depth 
analysis of glycosylation processes [6]. In conjunction with such mathematical 
modelling [6,37,38], the development of high-throughput experimental techniques for 
glycan and glyco-gene profiling [3–5,10] will further facilitate the systems analysis of 
glycosylation processes as successfully demonstrated in this study. 
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Table 1. Characteristics of enzymes used in network construction. Substrate for each 
enzyme should fulfill all the required conditions. For the specific description of glycosidic 
linkages, refer to glycan structures in Figure 1. ManI: mannosyl-oligosaccharide 1,2-α-
mannosidase; ManII: mannosyl-oligosaccharide 1,3-1,6-α-mannosidase; GnTI: α-1,3-mannosyl-
glycoprotein 2-β-N-acetylglucosaminyltransferase; GnTII: α-1,6-mannosyl-glycoprotein 2-β-N-
acetylglucosaminyltransferase; GnTIII: β-1,4-mannosyl-glycoprotein 4-β-N-
acetylglucosaminyltransferase; GnTIV: α-1,3-mannosyl-glycoprotein 4-β-N-
acetylglucosaminyltransferase; GnTV: α-1,6-mannosyl-glycoprotein 6-β-N-
acetylglucosaminyltransferase; FucT: glycoprotein 6-α-L fucosyltransferase; GalT: β-N-
acetylglucosaminylglycopeptide β-1,4-galactosyltransferase; SiaT: β-galactoside α-2,3/6-
sialyltransferase. 
 
Enzyme Substrate requirement Catalyzing reaction 
ManI Free α1,2-linked mannose Ordered removal of free α1,2-linked mannose 
(Materials and Methods) 
ManII Free α1,3- or α1,6-linked mannose following α1,6-linked mannose 
Free β1,2-linked N-acetylglucosamine following α1,3-linked mannose 
No bisecting β1,4-linked N-acetylglucosamine 
Removal of free α1,3- and α1,6-linked mannoses 
GnTI Unique structure of 5-mannose glycan just processed by ManI Addition of β1,2-linked N-acetylglucosamine to 
α1,3-linked mannose following β1,4-linked 
mannose 
GnTII No extra mannose other than three in the core 
No β1,2-linked N-acetylglucosamine following α1,6-linked mannose 
Free β1,2-linked N-acetylglucosamine following α1,3-linked mannose 
No bisecting β1,4-linked N-acetylglucosamine 
Addition of β1,2-linked N-acetylglucosamine to 
α1,6-linked mannose 
GnTIII No bisecting β1,4-linked N-acetylglucosamine 
β1,2-linked N-acetylglucosamine following α1,3-linked mannose 
No β1,4-linked galactose 
Addition of bisecting β1,4-linked N-
acetylglucosamine 
GnTIV No β1,4-linked N-acetylglucosamine following α1,3-linked mannose 
Free β1,2-linked N-acetylglucosamine following α1,3-linked mannose 
No bisecting β1,4-linked N-acetylglucosamine 
Addition of β1,4-linked N-acetylglucosamine to 
α1,3-linked mannose 
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GnTV No β1,6-linked N-acetylglucosamine 
Free β1,2-linked N-acetylglucosamine following α1,6-linked mannose 
No bisecting β1,4-linked N-acetylglucosamine 
Addition of β1,6-linked N-acetylglucosamine 
FucT No α1,6-linked fucose 
β1,2-linked N-acetylglucosamine following α1,3-linked mannose 
No bisecting β1,4-linked N-acetylglucosamine 
No β1,4-linked galactose 
Addition of α1,6-linked fucose 
GalT Free N-acetylglucosamine following either of α1,3- or α1,6-linked 
mannose 
Addition of β1,4-linked galactose to free N-
acetylglucosamine following either of α1,3- or 
α1,6-linked mannose 
SiaT Free β1,4-linked galactose Addition of sialic acid to free β1,4-linked 
galactose 
 
 
Materials and Methods 
 
Network Construction 
 N-linked glycosylation pathways were constructed by enumerating N-linked glycan 
structures commonly observed in mammalian cells [39], starting from the input 
substrate shown in Figure 1, which results from an oligosaccharide precursor in the ER 
with three glucose residues trimmed out. In our attempts to build consecutive enzymatic 
steps, we used ten enzymes constituting a large proportion of the mammalian N-linked 
glycosylation processes. The mannosidases (ManI and ManII) are exoglycosidases that 
remove mannose groups from N-linked glycans. The other eight enzymes are 
glycosyltransferases that catalyze the formation of glycosidic bonds. Five N-
acetylglucosaminyltransferases (GnTI, GnTII, GnTIII, GnTIV, and GnTV) were 
considered for the addition of GlcNAc, and FucT, GalT, and SiaT for the addition of 
fucose, galactose, and sialic acid, respectively. 
 Based on previous in vivo observations, the removal of α1,2-linked mannoses by ManI 
was considered in the following order [40,41]: ER resident ManI removes free α1,2-
linked mannose attached to α1,3-linked mannose in the initial input substrate and then 
Golgi resident ManI removes each of two remaining free α1,2-linked mannoses 
successively, making 6-mannose and then 5-mannose glycans. For the remaining 
enzymatic reactions, we applied the substrate specificity data shown in Table 1 obtained 
from publicly available literatures [37,42,43]. Except GnTI which uses only one 
substrate, the other enzymes could catalyze reactions that involve the same glycosidic 
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linkage on a range of different substrates. Finally, by taking into account only the 
pathways to be terminated at glycans containing mannoses no more than three in the 
core residue, we integrated pathways to produce mainly complex-type glycans for 
clarity of analysis. The resulting pathways are represented by a directional graph in 
which the vertices stand for glycan species and the edges for glycan synthetic reactions 
with arrows pointing from substrates to products. 
 
Network Decomposition into Subunits 
 The essentiality of individual glycans in the pathways was investigated by perturbing 
the pathways through the removal of single glycans. For each removal, we calculated 
how many glycans could not be produced due to the complete absence of their substrate 
production. The removal for most of the glycans gave only negligible effects (smaller 
than the cut-off in Figure 2B), and accordingly, we grouped the remaining glycans, 
whose removal had large effects, into those in the central region together with the early 
glycans processed by ManI. Glycans in the central region were located adjacent to each 
other, forming a self-jointed subgraph and containing root vertices linked to the non-
central or peripheral region. Different criteria for the central region did not affect the 
main results presented here as long as the cut-off was set between 2~8 (Figure 2B). 
 The peripheral region could be further partitioned by maximizing modularity Q for 
directional graphs [44]: 
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
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where Aij is 1 if there is an edge from vertex j to vertex i and, otherwise 0. kiin and kjout 
are the numbers of incoming and outgoing edges of the vertices, m is the total number 
of edges in the graph, δij is the Kronecker delta symbol, and ci is the label of the 
partition to which vertex i is assigned. Search for the division of the graph into 
partitions {ci} maximizing Q is known to be NP-complete, thus we used the spectral 
optimization method [44], which is both computationally efficient and practically 
acceptable in terms of partitioning results. For this purpose, we pre-assigned the central 
region a partition and recursively decomposed the peripheral region based on the 
spectral method (Q = 0.83). The resulting partitions or modules in the peripheral region 
were labelled in ascending order of the number of constituent glycans. The results of 
such partitioning on the glycosylation pathways remained robust when an alternative 
method that was designed for bidirectional or undirected graphs was applied by 
ignoring the edge directions [26]. Automatic decomposition of all the pathways, 
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including the central region, yielded only a slight increase in modularity (∆Q = 0.02), 
and this result was excluded to prevent method-specific over-partitioning that does not 
convey any information of biological significance. 
 
Glycan Synthesis Regulation 
 To evaluate the effect of transcriptional regulation on glycan synthesis, each enzyme i 
was assigned variable Ei depending on its regulated state: Ei = 1 if up-regulated, Ei = 0 
if neutral, and Ei = –1 if down-regulated. In addition, let Gij be 1 if enzyme i is involved 
in synthesizing glycan j and, otherwise 0. Likewise, Mjk is 1 if glycan j is located at the 
entry of module k and, otherwise 0. To focus on unambiguous cases in the prediction of 
regulatory effects, we only considered the combinations of Eis that satisfied the 
following rules simultaneously: 
(1) Ei · Ei’ ≥ 0 for every pair of i and i’ satisfying Gij = Gi’j = 1, when the given j and 
k satisfy Mjk = 1. Hence, the mixture of both up- and down-regulated enzymes to 
synthesize a particular glycan at the entry of any given module was excluded. 
(2) 0
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

⋅





∑∑
i
iji
i
iji GEGE  for every pair of j and j’ satisfying Mjk = Mj’k = 1 
with a given k. Hence, the mixture of both enhanced and suppressed glycan 
production at the entry of a particular module was excluded. 
Furthermore, we kept EManI = ESiaT = 0 and EGalT ≥ 0 to avoid an otherwise global and 
unspecific impact on glycan synthesis across modules. Each module k could be assigned 








=Φ ∑
ji
jkijik MGEH
,
 where H(x) = 1, 0, or –1 if x > 0, x = 0, or x < 0, respectively. 
Although Φk can be 1, 0, or –1, these three numbers did not appear simultaneously for 
any combination of Eis. For example, some particular combination of Eis allowed Φks to 
take 1 and 0, but never observed was a combination allowing them to take all of 1, 0, 
and –1. Here we considered the cases where two of 1, 0, and –1 were taken by Φks for 
given Eis. Because we were interested in the regulatory cases keeping a similar level of 
the influx of the starting substrate for which modules compete with each other, modules 
assigned Φk larger than the other were expected to have enhanced glycan production 
relative to their basal levels, and were otherwise suppressed. (Table S1). For example, 
modules assigned Φk = 1 were regarded as enhanced while the others assigned Φk = 0 
were regarded as suppressed. One can easily prove that such a regulatory effect remains 
invariant to applying both Ei → –Ei and permutations of enhanced and suppressed 
modules. We also examined alternative regulatory models, such as explicitly 
 17 
considering the substrate competition between reactions, but the results did not differ 
much from the present results. 
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Supplementary Materials 
 
Figure S1. Entry and terminal glycans of peripheral modules. For each module, the 
parent glycans in the central region and the corresponding reactions are also depicted. 
The bulk of each module is dominated by galactosylation and sialylation. 
 
Figure S2. Reactions between glycans belonging to different modules. 
 
Table S1. Lists of enhanced or suppressed modules under combinations of enzyme 
regulation. For the comparison with Figure 3(B), the most right column labels each 
regulatory outcome in which no more than six modules become enhanced. 
 


1Regulated Enzyme Affected Module
Up-regulated Down-regulated Enhanced Suppressed
GnTII, GnTIII, FucT 1 2~21
GnTII, GnTIII, GnTIV, FucT 1 2~21
GnTII, GnTIII, GnTIV, GnTV, FucT 1 2~21
GnTII, GnTIII, GnTV, FucT 1 2~21
GnTIII, GnTIV, GnTV, FucT 1 2~21
GnTII, GnTIII, GnTIV 1, 2 3~21
GnTII, GnTIII, GnTIV, GnTV 1, 2 3~21
GnTIII, GnTIV, GnTV 1, 2 3~21
GnTII, GnTIV, FucT 1, 3 2, 4~21
GnTII, GnTIV, GnTV, FucT 1, 3 2, 4~21
GnTIII, GnTIV, FucT 1, 16 2~15, 17~21 4
GnTIII, GnTV, FucT 1, 17 2~16, 18~21 5
GnTII, FucT 1, 3, 5 2, 4, 6~21
GnTII, GnTV, FucT 1, 3, 5 2, 4, 6~21
GnTIV, GnTV, FucT 1, 3, 7 2, 4~6, 8~21 7
GnTII, GnTIII 1, 2, 9 3~8, 10~21
GnTII, GnTIII, GnTV 1, 2, 9 3~8, 10~21
GnTII, GnTIV 1~4 5~21
GnTII, GnTIV, GnTV 1~4 5~21
GnTIII, GnTIV 1, 2, 15, 16 3~14, 17~21 10
GnTIII, FucT 1, 16~18 2~15, 19~21 11
GnTIII, GnTV 1, 2, 9, 14, 17 3~8, 10~13, 15, 16, 18~21 12
GnTIV, FucT 1, 3, 7, 12, 16 2, 4~6, 8~11, 13~15, 17~21 13
GnTIV, GnTV 1~4, 7, 8 5, 6, 9~21 14
GnTV, FucT 1, 3, 5, 7, 10, 17 2, 4, 6, 8, 9, 11~16, 18~21 15
GnTII 1~6, 9 7, 8, 10~21
GnTII, GnTV 1~6, 9 7, 8, 10~21
GnTV 12, 13, 15, 16, 18~21 1~11, 14, 17
GnTIII 1, 2, 9, 14~19 3~8, 10~13, 20, 21
GnTIV 1~4, 7, 8, 12, 13, 15, 16 5, 6, 9~11, 14, 17~21
FucT 1, 3, 5, 7, 10, 12, 16~18, 20 2, 4, 6, 8, 9, 11, 13~15, 19, 21
FucT 2, 4, 6, 8, 9, 11, 13~15, 19, 21 1, 3, 5, 7, 10, 12, 16~18, 20
GnTIV 5, 6, 9~11, 14, 17~21 1~4, 7, 8, 12, 13, 15, 16
GnTIII 3~8, 10~13, 20, 21 1, 2, 9, 14~19
GnTV 1~11, 14, 17 12, 13, 15, 16, 18~21
GnTII 7, 8, 10~21 1~6, 9
GnTII, GnTV 7, 8, 10~21 1~6, 9
GnTV, FucT 2, 4, 6, 8, 9, 11~16, 18~21 1, 3, 5, 7, 10, 17
GnTIV, GnTV 5, 6, 9~21 1~4, 7, 8
GnTIV, FucT 2, 4~6, 8~11, 13~15, 17~21 1, 3, 7, 12, 16
GnTIII, GnTV 3~8, 10~13, 15, 16, 18~21 1, 2, 9, 14, 17
GnTIII, FucT 2~15, 19~21 1, 16~18
GnTIII, GnTIV 3~14, 17~21 1, 2, 15, 16
GnTIV, GnTV, FucT 2, 4~6, 8~21 1, 3, 7
GnTII, FucT 2, 4, 6~21 1, 3, 5
GnTII, GnTV, FucT 2, 4, 6~21 1, 3, 5
GnTII, GnTIII 3~8, 10~21 1, 2, 9
GnTII, GnTIII, GnTV 3~8, 10~21 1, 2, 9
GalT 1, 2, 5~21 3, 4
8
9
1
2
3
6
2Regulated Enzyme Affected Module
Up-regulated Down-regulated Enhanced Suppressed
GnTII, GalT 1, 2, 5~21 3, 4
GnTII, GnTIV, GalT 1, 2, 5~21 3, 4
GnTII, GnTIV, GnTV, GalT 1, 2, 5~21 3, 4
GnTII, GnTV, GalT 1, 2, 5~21 3, 4
GnTIV, GalT 1, 2, 5~21 3, 4
GnTIV, GnTV, GalT 1, 2, 5~21 3, 4
GnTV, GalT 1, 2, 5~21 3, 4
GnTIII, GnTV, FucT 2~16, 18~21 1, 17
GnTIII, GnTIV, FucT 2~15, 17~21 1, 16
GnTII, GnTIV, FucT 2, 4~21 1, 3
GnTII, GnTIV, GnTV, FucT 2, 4~21 1, 3
GnTII, GnTIII, GnTIV 3~21 1, 2
GnTII, GnTIII, GnTIV, GnTV 3~21 1, 2
GnTIII, GnTIV, GnTV 3~21 1, 2
GnTII, GnTIV 5~21 1~4
GnTII, GnTIV, GnTV 5~21 1~4
FucT, GalT 1, 2, 4~21 3
GnTII, FucT, GalT 1, 2, 4~21 3
GnTII, GnTIV, FucT, GalT 1, 2, 4~21 3
GnTII, GnTIV, GnTV, FucT, GalT 1, 2, 4~21 3
GnTII, GnTV, FucT, GalT 1, 2, 4~21 3
GnTIV, FucT, GalT 1, 2, 4~21 3
GnTIV, GnTV, FucT, GalT 1, 2, 4~21 3
GnTV, FucT, GalT 1, 2, 4~21 3
GnTII, GnTIII, FucT 2~21 1
GnTII, GnTIII, GnTIV, FucT 2~21 1
GnTII, GnTIII, GnTIV, GnTV, FucT 2~21 1
GnTII, GnTIII, GnTV, FucT 2~21 1
GnTIII, GnTIV, GnTV, FucT 2~21 1
